Landrieu P
Hôpital de Bicêtre, Paris.
Rev Neurol (Paris). 1992;148(2):97-106.
Recent advances in biological techniques have resulted in an ever increasing number of neurogenetic diseases being characterized at molecular level or mapped by polymorphic markers which provide the diagnosis. Thus, side by side with the management of the patients, a genetic management extended to the family is progressively taking shape. This familial care is not without technical and ethical problems.